Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, PRospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the treatMEnt of Post-operative Inflammation in Patients Who Plan to Undergo Refractive Lens Exchange (RLE)

NCT04549935 is registered in ClinicalTrials.gov with Vance Thompson Vision - MT as lead sponsor.

NCT NCT04549935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04549935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, PRospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the treatMEnt of Post-operative Inflammation in Patients Who Plan to Undergo Refractive Lens Exchange (RLE)
Lead sponsor
Vance Thompson Vision - MT
Phase
Phase 4
Overall status
Recruiting
Start date
September 14, 2020
Completion date
August 27, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

grade of post-operative cystoid macular edema, patient outcomes, patient preference, post-operative inflammation, rate of post-operative cystoid macular edema